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A MAJOR GOAL OF BIOLOGY is to understand how single cells build structure and function across large volumes of tissue. This unifying understanding is particularly important in the colorectal mucosa, where abnormal functions or interactions of various host and microbial cell types can lead to pathologies, such as ulceration, inflammation, and tumorigenesis, that affect macroscopic regions. To achieve improved visualization of biological processes, one powerful approach is to chemically "clear" the tissue of interest (i.e., normalize refractive indexes within the tissue, making it transparent), thereby enabling through deep confocal fluorescence imaging the study of cellular structures within their native tissue context. The promise of tissue clearing has been demonstrated in a variety of systems, including the nervous system (12, 13) , intestines (15) , kidney (7) , airway (34) , and vasculature (23) ; however, early clearing agents had important limitations such as their insufficient clearing, distortion of tissue architecture, quenching of fluorescent proteins, or proprietary recipes leading to exorbitant cost. These limitations have been partly alleviated by the development of newer clearing agents and approaches, such as ScaleA2 (17) , SeeDB (19) , CLARITY (6) , CUBIC (37) , and PACT (44) , which overall support the utility of tissue clearing in reconstructing organ architecture using deep, single-photon confocal imaging. However, experimental workflows incorporating the use of clearing agents need to be developed for each organ and must consider the chemical properties of each clearing agent. Moreover, in murine colorectal mucosa it has not been fully determined what normal and pathological structures can be elucidated using a clearing methodology.
We report here a series of dissection, clearing, and imaging methods, collectively termed deep mucosal imaging (DMI), that enable complete optical reconstruction of large volumes of mouse distal colonic mucosa at cellular resolution. Usage of two clearing agents, ScaleA2 (17) and SeeDB (19) , first described in brain effectively cleared distal colonic mucosal tissue such that the intestinal crypt could be visualized from its base up to the luminal surface in whole mount preparations. To facilitate investigation of large tissue volumes, we combined tissue clearing with tiled image acquisition. We provide software routines to manage the large image files. We show that DMI facilitates the visualization of colonic epithelial structures involved in acute injury, chronic inflammation, and tumorigenesis. The DMI technique excels when analyzing genetically modified fluorescent reporter mice and can be extended to study human colonic biopsy specimens and archived tissue. We believe that the incorporation of DMI will enhance mechanistic studies of colorectal function and dysfunction and that the principles of this technique will extend to studies along the entire gastrointestinal tract.
MATERIALS AND METHODS

Mice
Mice were maintained humanely and ethically, in accordance with the rules and regulations of the Institutional Animal Care and Use Committee (IACUC) of Children's Hospital Los Angeles (CHLA). This study was approved by the CHLA IACUC under the internal protocol number 288. Before dissection, mice were anesthetized with isoflurane and killed via cervical dislocation.
Lgr5::EGFP-IRES-CreER T2 mice (2), Rosa26::tdTomato (Ai14) mice (25) , mTmG mice (29) , and IL-10 Ϫ/Ϫ mice on the C57Bl/6J background were obtained from Jackson Laboratory. Lgr5::EGFP-IRES-CreER T2 were bred with Ai14 mice to generate Lgr5 trace mice.
Single intraperitoneal injections with 20 g tamoxifen (Sigma) prepared in corn oil were performed on these mice to induce lineage tracing for trace durations of 7-56 days.
Dextran Sulfate Sodium Injury Model
Before dextran sulfate sodium (DSS) injury, mice were trained to drink solely from water bottles by removing other sources of water for 1-3 days. To induce injury, mice were supplied with water bottles containing 3% wt/vol DSS (36 -50 kDa mol mass; MP Biomedicals) in distilled water, which served as their only source of drinking water for 6 days. During the recovery period (after injury), mice were removed from the DSS source and were switched to regular drinking water. Mouse weight and stool consistency were periodically examined to validate onset of colonic injury.
Human Tissue
Deidentified incidental pediatric human colonic tissue was collected in the course of necessary intestinal resection surgery in a patient at CHLA. Tissue was transferred to the research laboratory following all regulations. The human colonic specimen was fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) at 4°C for ϳ6 mo before use in experiments. Mucosal biopsy specimens were obtained from this fixed specimen using a pediatric Radial Jaw biopsy forceps (2.0 mm; Boston Scientific).
Paraffin-Embedded Mouse Tissue
Paraffin-embedded blocks of colonic tissue were obtained from mice subjected to the azoxymethane (AOM)/DSS tumorigenesis model from a previous study (11) . Excess paraffin was trimmed from the tissue and melted at 60°C. The freed tissue was sequentially incubated in 100% xylenes, 100% xylenes, 100% ethanol, 70% ethanol, 50% ethanol, 20% ethanol, distilled water, and PBS (10 min each).
Dissection
Whole colon was removed from dead mice. Colons were opened longitudinally and rinsed of fecal contents, flattened, and fixed overnight in freshly prepared, methanol-free 4% PFA in PBS at 4°C. After three rinses in PBS, the distalmost 3-5 cm of colon was removed for further dissection. In both freshly fixed and paraffin-restored distal mouse colonic tissue, the myenteric layer was carefully freed from the mucosal layer under a dissecting microscope using fine forceps and microvannas scissors.
Histochemistry
Primary antibodies included rabbit anti-MPO (1:300, catalog no. ab45977; Abcam), rabbit anti-MUC2 (1:100, catalog no. sc-15334; Santa Cruz Biotechnology), and rat anti-CDH1 (1:200, catalog no. 13-1900; Life Technologies). Secondary antibodies included a goat anti-rabbit Alexa Fluor 555 conjugate (8 g/ml; Life Technologies) and goat anti-rat Alexa Fluor 555 conjugate (8 g/ml; Life Technologies).
For immunostaining, isolated contiguous murine distal colonic mucosal samples or human biopsies were permeabilized for 4 h at room temperature with PBTx-block-0.3% Triton X in PBS supplemented with 4% horse serum (Vector Labs). Samples were incubated with primary antibody for 60 h at 4°C in PBTx-block. Following four washes with PBS (1 h each), tissue was simultaneously incubated with secondary antibody and 5 g/ml Hoechst 33342 (Life Technologies) or 0.2 M TO-PRO-3 iodide (Life Technologies) in PBTx-block at 4°C overnight. After being washed with PBS (4 times, 1 h each), samples were ready for SeeDB clearing.
For antibody-free labeling with various dyes before SeeDB clearing, tissue was incubated with 2 g/ml Hoechst 33342, 0.2 M TO-PRO-3 iodide, or 1 U/ml phalloidin-DyLight 488 conjugate (Thermo Scientific), or a combination of the three dyes, prepared in 0.3% Triton X in PBS for 1-3 days at 4°C. After being washed with PBS, samples were cleared in SeeDB (see below).
Clearing
ScaleA2. ScaleA2 (17) aqueous solution contained 4 M urea, 0.1% wt/vol Triton X, and 10% wt/wt glycerol. Murine distal colonic mucosal strips were sandwiched between strips of blotting paper and skewered on a 30-gauge syringe needle before placement in ScaleA2. This setup prevented curling of specimens over time. All specimens were incubated in ScaleA2 at 4°C for Ͼ21 days. At 3 days before imaging, Hoechst 33342 or TO-PRO-3 iodide was added to ScaleA2 incubation solution to a working concentration of 5 g/ml (Hoechst) or 0.2 M (TO-PRO-3).
SeeDB. Human and mouse specimens were placed in 20% wt/vol fructose/water solution and frozen at Ϫ20°C for 1-7 days. Upon defrosting, specimens were moved to 40% wt/vol fructose/water (1 h), 70% wt/vol fructose/water (1 h), and 100% wt/vol fructose/water (2-6 h) at room temperature. Specimens were moved to SeeDB solution for overnight incubation at room temperature. SeeDB (19) aqueous solution was composed of 80.2% wt/wt fructose and 0.5% vol/vol 1-thioglycerol. Some human biopsy samples were digested with 0.1% wt/vol collagenase D (Roche) in HEPES-buffered saline (in mM: 136 NaCl, 2.5 KCl, 10 HEPES, 2 CaCl 2, 1.3 MgCl2, and 10 D-glucose, pH 7.4) at 37°C before clearing in SeeDB; this additional preprocessing step was tested for its ability to enhance penetration of SeeDB into heavily fixed tissue.
Mounting
ScaleA2-cleared samples. Specimens were removed from ScaleA2 solution, dried on blotting paper, and flattened on no. 1 24 ϫ 60 mm cover glass. Drops of ScaleA2 were added to rehydrate the specimen minimally; bubbles were gently pushed out of the specimen with a pipette tip. A no. 1 24 ϫ 30 mm cover glass was placed on top of the specimen, and additional ScaleA2 was added with a transfer pipette through the side of the cover glass "sandwich."
SeeDB-cleared samples. Specimens were removed from viscous SeeDB and flattened on a no. 1 24 ϫ 60 mm cover glass containing a drop of SeeDB preequilibrated with specimen. A no. 1 24 ϫ 30 mm cover slip was added to the top to affix the specimen.
Imaging
Mounted samples were allowed to equilibrate in the mounting setup for 15 min before imaging. Samples were imaged on a Zeiss LSM700 confocal inverted microscope, with Fluar 5ϫ/0.25 numeric aperture (NA), Plan-NeoFluar 10ϫ/0.3 NA, or Plan-Apochromat 20ϫ/0.8 NA air objectives. Pinhole size was set to 1 Airy unit. Tiled images were acquired with an overlap of 10%. Refractive index matching was performed within the Zen (Zeiss) software; refractive indexes of 1.38 and 1.45 were used for ScaleA2-and SeeDB-cleared samples, respectively. Typical scans were executed over a duration of 6 -14 h. z"), compensation for bleedthrough ("Subtract bleedthrough"), and feature isolation with volume rendering ("Set cast"). All image analysis was performed on a standard 2.8 GHz/i7/8 GB desktop computer.
Analysis of DSS Injury
Quantification was performed on images using built-in measurement functions in ImageJ combined with interfacing routines in the DMI package. Luminal images of CDH1-labeled colorectal mucosa were thresholded, and the DMI plugin "Injury counter 2" automatically calculated the percent of negatively stained surface along the proximal-distal axis, which yielded a profile of the ulceration along the length of the mouse colon. The accuracy of the results was checked using the manual "Injury counter" function of the DMI package. To calculate the fractional surface occupancy of highlighted epithelial features (e.g., restitution, neoepithelium, aberrant crypt repair structures) in DSS recovery, regions of interest were manually traced from luminal z projections and subsequently sized and scaled to the total surface area. A full list of functions and use cases in the DMI package is provided in the software documentation.
Statistical tests and hierarchical clustering were performed in R.
RESULTS
Development of DMI
The DMI method combines physical isolation of colorectal mucosa with chemical clearing to enable deep (z plane) imaging of whole mounted specimens using single-photon confocal microscopy. Large expanses (x-y plane) of the opened mucosal surface could be captured in full z depth by tiling of acquired images (Fig. 1A) . The x-y plane in acquired images was orthogonal to the conventional plane of tissue cross sections. In DMI, the microscope objective could be placed on the luminal side (luminal imaging) or submucosal side (abluminal/basilar imaging) to optimize resolution at the luminal surface or at the base of the intestinal crypt, respectively ( Fig. 1, B-D) . Because individual image data sets could exceed 25 GB, we developed open-source convenience routines to facilitate reconstruction and exploration of DMI images on computers with standard memory allotments (ϳ8 GB RAM), obviating the need for proprietary software or state-of-the-art hardware.
Application of Clearing Agents to Murine Colorectal Tissue
A major goal of the DMI technique was mucosal visualization through the full extent of the murine colonic crypt. In the distal colon and rectum, this required dissection of colonic muscle layers from the mucosa (Fig. 1E) . We then tested the efficacy of chemical clearing agents on colorectal mucosa. Both urea-based (ScaleA2) and fructose-based (SeeDB) clearing agents (17, 19) reduced light scattering through mucosal tissue ( Fig. 2A) . Luminal microscopic images showed resolution of cleared, tdTomato-labeled cellular membranes (from mTmG mice; see Ref. 29) at Ͼ30 m beneath the luminal surface, beyond the resolving depth in uncleared samples (Fig.  2B) . In abluminal images, chemical clearing enabled resolution of tdTomato fluorescence in the colonic crypt fully from the basilar lamina propria to the mucosal surface (Fig. 2C) . A digital orthogonal representation that emulated the classic tissue sectioning plane could be derived from abluminal DMI images (Fig. 2D ). These orthogonal representations indicated that the practical z-resolution of the DMI technique was determined by the optical section thickness and pinhole size set during the z-stacking procedure. Although the z-resolution is fundamentally limited by the point-spread function, optical sectioning at ϳ2-m thickness with a 20ϫ/0.8 NA objective yielded images with subcellular axial resolution. Cleared colonic crypts stained with exogenous Hoechst nucleus-labeling dye could also be reconstructed in abluminal images (Fig. 2 
, E and F).
We compared the effects of tissue clearing on preservation of fluorescent protein signal and tissue morphology. We imaged colonic crypts derived from equivalent regions along the proximal-distal axis in mTmG (n ϭ 5 mice, Ͼ20 crypts/ mouse) and Lgr5::EGFP-IRES-CreER T2 mice (2) (n ϭ 3 mice, Ͼ20 crypts/mouse). Crypts were either treated with PBS, ScaleA2, or SeeDB. SeeDB clearing resulted in an approximately fourfold reduction in membrane-localized tdTomato fluorescence at the crypt base in mTmG mice (P Ͻ 0.01), whereas ScaleA2 had no impact (P ϭ 0.1, Fig. 2G ). Similarly, SeeDB significantly reduced cytoplasmic enhanced green fluorescent protein (EGFP) fluorescence of Lgr5::EGFP-IRESCreER T2 at the crypt base (P Ͻ 0.01), and ScaleA2 clearing resulted in a more modest reduction (P ϭ 0.01, Fig. 2H ).
However, the remaining fluorescence was still strong enough to perform deep imaging of cleared crypts and provided net benefit vs. uncleared samples (Fig. 2C) . Crypt cross-sectional areas were larger in ScaleA2-cleared tissue from mTmG mice; we calculated that ScaleA2 led to a linear sample expansion of 15 Ϯ 4% in each direction (P ϭ 0.01, n ϭ 5 mice, Ͼ20 crypts/mouse). SeeDB did not alter the apparent crypt size (Fig. 2I) . Clearing of colorectal mucosa required a 21-day incubation in ScaleA2 or a 1-day incubation in SeeDB. With SeeDB, the typical time from animal dissection to imaging was 5 days, and a 12 ϫ 8 ϫ 0.6 mm 3 volume of distal colonic tissue could be imaged in Ͻ16 h and digitally processed in Ͻ24 h. Imaging of more-proximal regions of colon was possible with the same clearing protocol; in midcolon, myenteric separation was not necessary to visualize colon fully with SeeDB clearing (Video 1 and Fig. 2J ).
Reconstruction and Immunostaining of Normal Mouse Colon
When stained for cellular nuclei, the normal adult murine distal colon exhibited a continuous array of crypts that had a grossly uniform appearance (Video 2) on the folded luminal mucosal surface. The continuous array of crypts terminated at the far-distal dentate line bordering the anal squamous epithelium (Fig. 3A) . In abluminal image stacks, the mesenchymal cell layer surrounding the crypt base, as well as portions of the submucosa, were the first layers to appear. Because of the contoured structure of the mucosa, the crypt bases were not all in the same z plane (Fig. 3B ). These images show that, in addition to resolving individual cellular nuclei (Fig. 2F) , DMI revealed the architectural patterns within colorectal tissue.
We next examined whether tissue clearing could enhance whole mount visualization of antibody-labeled samples. Figure  3C shows a three-dimensional (3D) reconstruction of SeeDBcleared, digitally isolated colonic crypt labeled with an antibody raised against CDH1 (E-cadherin). Luminal (Fig. 3D) and abluminal ( Fig. 3E ) images showed prominent membrane labeling by the CDH1 antibody at the luminal surface and crypt base, respectively. To examine the extent of antibody penetration in the colonic crypt, we washed out the clearing agent from the immunostained samples and analyzed them using mechanical sectioning: the images confirmed full CDH1 labeling throughout the basilar-luminal axis of the crypt (Fig. 3F ). These results demonstrate that DMI can be easily incorporated into an integrated experimental workflow that includes immunohistochemistry and mechanical sectioning.
DMI for Lineage Tracing of Epithelial Stem Cells
Because chemical clearing with ScaleA2 or SeeDB preserves native fluorescence of fluorescent proteins in gut (Fig.  2) ϩ stem cells enables their native visualization (through imaging for EGFP) and tamoxifen-inducible lineage tracing (2, 25) (through hereditary cytoplasmic tdTomato expression). These Lgr5 reporter mice exhibit a well-documented mosaic expression pattern, in that EGFP expression is only found in a minority of intestinal crypts despite the presence of Lgr5 ϩ stem cells in all of them (2, 39) . Because of worsening mosaicism at progressively distal locations in the gastrointestinal tract (2), few studies (9, 27) have analyzed Lgr5 ϩ stem cells specifically in colorectal mucosa, in spite of their potential importance in tumor growth and tissue regeneration.
DMI-derived images permitted visualization of Ͼ5,000 distal colonic crypts within a single sample (Fig. 4A ). In the distalmost 1 cm of colons from 10 mice, 10.6 Ϯ 1.4% of crypts harbored EGFP ϩ cells. Computerized hierarchical clustering demonstrated that the x-y locations of crypts with EGFP ϩ cells were grouped (Fig. 4, B and C) . We next tested the suitability of DMI to visualize the 3D lineages of colonic Lgr5 ϩ stem cells (Video 3). In Lgr5 trace mice, pulse tamoxifen injections at a dosage of 0.02 mg/animal induced the hereditary expression of tdTomato in an average of less than one stem cell per crypt (24) . After an 8-wk lineage-tracing period, clonal conversion was observed as fully labeled crypts that could be reconstructed in 3D (n ϭ 3 mice, Fig.  4D ). Performing a similar pulse-chase analysis (n ϭ 5 mice), but with a shorter chase period (7 days), enabled the visualization of the lineages of single stem cells before clonal fixation (42) . Figure 4E shows these lineages occupying stem cell, transit-amplifying, and differentiated cell zones of the colonic crypt. The absolute sizes of these clonal lineages could also be directly quantified; their aggregated statistical distribution (n ϭ 5 mice, 276 total crypts analyzed) is shown in Fig. 4F . Thus, DMI facilitates 3D lineage-tracing analysis throughout both stem-and differentiating-cell compartments in the mosaic Lgr5 trace mouse colon. 
Visualization of Injury and Regeneration in Chemically Injured Colon
Using DMI, we reconstructed the distal colons of mice administered 3% DSS through drinking water. The consumption of DSS over several days induces reversible epithelial destruction and inflammation of distal colon (31) . We imaged samples of the distalmost 1 cm of colonic mucosa at 0, 2, 4, and 14 days into the "recovery" period, after the withdrawal of DSS, and compared them with samples from untreated controls (n ϭ 4 mice/cohort). Figure 5 shows representative images of DSS-induced ulceration at these time points on the CDH1-immunostained distal colonic epithelial surface. Reproducible epithelial features found in every sample at the given time point are described and shown in greater detail in Fig. 6 . The spatial profiles of ulceration and regenerative epithelial changes are quantified and shown in Fig. 6, N and O. Moreover, a full video reconstruction of the mucosa at 4 days into the recovery period is shown in Video 4.
Ulceration and crypt loss. Ulceration was evident as a loss of CDH1 ϩ cells at the mucosal surface (Figs. 5 and 6, A-E). There were no glandular structures resembling crypts within the ulcerated region. The cells of the crypt-free region did not assemble into an obvious pattern. Ulceration was most pronounced at 2 and 4 days in the recovery period and had declined by 14 days. Within the very-distal region shown and analyzed, ulceration was first seen near the dentate line at 0 days recovery and had expanded to more-proximal areas at 2 days recovery (Fig. 5, A and B) . The healing pattern was apparent at 4 days recovery, in that proximal regions were covered by restitutive colonic epithelium and the most-distal region by neoepithelium (Fig. 5C) ; this is quantitatively demonstrated in Fig. 6N as a reduction in ulceration at the edges of the profile.
Restitution. At 2 and 4 days into the recovery period, mucosal regions containing CDH1 ϩ cells harbored crypt-like structures; however, unlike normal crypts, the openings of these structures onto the luminal surface were occluded by CDH1 ϩ cells (Fig. 6E) . CDH1 ϩ cells also extended from these crypt-like structures onto the surfaces of the ulcerated regions (Fig. 6, A-E and O) . A simple explanation for these observations is that DSS exposure activates epithelial restitutive (migratory) behaviors that cover injured regions with a superficial layer of reparative cells.
Aberrant crypt repair structures. These were prominent features of DSS-exposed mucosa at 14 days of recovery (Figs. 5D and 6O), and they could be qualitatively identified by their elongated openings onto the luminal surface (Fig. 6, F-I ). Surface and basilar projections, shown in Fig. 6H , of the 3D-reconstructed structures highlighted their dissimilarity to normal crypts (Fig. 6J) . Their elongated surface opening served to unify and bind multiple nascent crypts that budded from the base (Fig. 6H) . In thin optical and orthogonal cross sections, aberrant crypt repair structures looked like aberrant crypt foci but lacked evidence of dysplasia (Fig. 6, G and I) . Aberrant crypt repair structures were also seen in tissue examined after 4, 6, and 8 wk of recovery (n ϭ 1 for each time point, data not shown), suggesting that some of them can be longlived structures. We did not quantify their representation of the mucosal surface area at these later times. Aberrant crypt repair structures may be related to the so-called "wound channels" observed in biopsy models of colonic injury (28) .
Neoepithelium. A squamous-like, CDH1 ϩ epithelium was consistently found adjacent to and proximal of the dentate line, beginning at 0 days into the recovery period (Fig. 5A) , but was never found in normal colonic tissue. The colorectal surface area covered by this neoepithelium increased over time after recovery from DSS injury (Figs. 5, B-D, and 6O) . Deeper imaging showed that the base of the squamous-like epithelium had structures that resembled rete ridges (rete pegs) (Fig. 6,  K-M) . This far-distal feature of colonic injury is rarely reported, but its origins may be related to the anal squamous epithelium (32) .
Optical Reconstruction of Chronically Inflamed Colon
We analyzed colorectal mucosae obtained from a total of three IL-10 Ϫ/Ϫ mice, a genetic inflammatory bowel disease (IBD) model characterized by spontaneous colitis that appears in the first several months of life and intensifies with age (21) . Two mice were 60 wk old at dissection, and the other mouse was 16 wk old; these two ages roughly correspond to moderate and mild colitis, respectively, in our facility. No marked ulcerations or crypt abscesses were identified within the distalmost 1 cm of the examined colons (Video 5), consistent with limited epithelial damage reported for IL-10 Ϫ/Ϫ mice maintained on the C57Bl/6 inbred background (3, 4, 14) . However, in the 60-wk-old samples the rectal mucosa qualitatively exhibited small regions of crypt disfiguration accompanied by increased cellular number in the lamina propria (Fig. 7, A-D) . Within these regions DMI simplified the identification and counting of crypt fission events (Fig. 7, E and F (41), provided 3D perspective on immune cells associated with colonic crypts (Fig. 7G ) in these IL-10 Ϫ/Ϫ specimens. Thus, DMI is suitable for the detailed analysis of mucosal structure in chronically inflamed colonic tissue.
Visualizing Colonic Epithelial Dysplasia in Archived Specimen
To visualize crypt architecture in tumorigenesis, and to test whether DMI could reconstruct archived paraffin-embedded intestinal samples, we restored a distal colonic specimen from a single mouse subjected to the AOM-DSS polyposis model for 2 mo. In this model, polyp formation in distal colonic mucosa is accelerated by DSS injury in mice injected with the AOM mutagen (30, 38) . After clearing, normal regions of colonic mucosa could be visualized in toto, indicating efficacy of SeeDB-based clearing of archived samples. Polyps could be imaged ϳ160 m deep with single-photon confocal microscopy; however, because of their thickness it was not possible to reconstruct them totally.
DMI enabled continuous examination of external structures at and internal structures near the tumor perimeter (Video 6). As shown in Fig. 8A , the tumor surface was observed to be multilobular. In contrast to normal colon, where numerous openings from the luminal surface led into crypts, the tumor surface was mostly sealed by a surface layer of cells, despite the crypt-like structures present underneath (Fig. 8B) . Inside the tumor, crypt-like structures organized into aberrant crypt foci and adopted complex and variable structures (Fig. 8C) . In abluminal images, distortion of nuclear shapes indicated high-grade dysplasia of crypt-like structures at the tumor base (Fig. 8, D and E) . These images also qualitatively supported a thickening of the submucosal and stromal elements near the tumor (data not shown).
Use of DMI in Human Tissue
To determine whether DMI enhanced the analysis of human intestinal tissue, we obtained pinch biopsies from a fixed colonic pediatric surgical specimen. Although it did not fully clear the specimen, SeeDB treatment improved optical penetration and reconstruction of subsurface crypt structure (Video 7). Mild digestion of the tissue with collagenase further enhanced optical penetration but reduced the Fig. 5 . DMI enabled novel visualization of dextran sulfate sodium (DSS)-induced injury of colorectal mucosa. DSS (3%) was administered to mice for 6 days, and the distalmost 1 cm of CDH1-immunostained colonic mucosa was luminally imaged at 0 (A), 2 (B), 4 (C), and 14 (D) days into the recovery period (after the removal of DSS). Regions lacking the red signal are CDH1-negative and devoid of intact epithelium; these regions represent ulcerations. The general locations of other features (restitution, neoepithelium, and aberrant crypt repair structures) are also indicated on these representative images. Clearing, SeeDB. Scale bars ϭ 1,000 m. resolution at the mucosal surface (Fig. 9A ). Similar to mouse colorectal tissue, biopsied crypts could be visualized in both luminal and abluminal orientations (Fig. 9B) . Crypt bases could be examined through remnant submucosal and muscle layers (Fig. 9C) . Cellular resolution could be obtained within the sample (Fig. 9D) , and DMI allowed 3D reconstruction of the crypt base (Fig. 9E) . Human colonic biopsies could be characterized by phalloidin staining for actin (Fig. 9, A-E) and by immunolabeling for the mucous protein and goblet cell marker MUC2 (Fig. 9F) . Thus, DMI combined with exogenous dyes and antibodies generated a novel view of human colonic biopsies.
DISCUSSION
The colon has a central role in health and disease; thus, this organ serves as an excellent model for understanding biological phenomena through improved visualization of tissue architecture. We have developed a novel approach to generate extended volume representations of murine colorectal mucosa at cellular resolution. The combination of chemical clearing of colonic tissue, tiled 3D confocal imaging, and software routines enabled in toto visualization of epithelial changes during colonic injury, inflammation, and tumorigenesis. Structural information from DMI may be combined in the future with whole organ functional imaging [e.g., using activatable nearinfrared probes that read inflammation (5, 10) or dysplasia (16) ] to define precise tissue states in health and disease. While previous approaches for 3D imaging of intestinal tissue (1, 15, 36) have led to important discoveries (e.g., see Ref. 35) , especially pertaining to epithelial stem cell renewal and differentiation, the DMI technique has key advantages. Compared with approaches that require mechanical sectioning (36), the DMI technique allows continuous observation of features across a larger x-y expanse of the mucosal surface. Thus, DMI is well suited for visualization of contiguous mucosal changes at length scales involving multiple colonic crypts and through the full crypt volume. In contrast to other methodologies (12, 15, 23, 34, 45) , the DMI technique uses simple, low-cost reagents (e.g., urea, fructose) and obviates the need for tissue dehydration and shrinkage to achieve sufficient clearing. As shown in Figs. 1, 2 , and 4, DMI allows native visualization of both cytoplasmic and membrane-targeted fluorescent proteins. DMI is readily incorporated into experimental workflows that require immunostaining, mechanical sectioning, and tissue archival and restoration (Fig. 10) . The protocols and software of DMI are fully open, and because they can be performed with relatively standard single-photon confocal microscopes, they have reduced barriers to adoption. We believe these advantages will make DMI an important tool for the replicative imaging of specimens to understand biological processes, including inflammation and tumorigenesis, that are of clinical relevance.
Limitations and Future Improvements
Advances in microscopy and tissue clearing may further improve the resolution, depth, and speed of the DMI technique.
Resolution. With standard air objectives and single-photon excitation on a laser-scanning confocal microscope, we reconstructed colonic crypts at a minimum optical z-thickness of ϳ2 m, which is sufficient to resolve individual cellular nuclei but represents a relative loss of resolution through the crypt depth compared with techniques that mount the intestinal crypt on its side. The use of objectives that have longer working distances, higher NAs, and optimal performance at high refractive index will improve the z-resolution and accuracy of the DMI technique.
Depth. While not required to reconstruct normal mouse colorectal mucosa, multiphoton excitation may help for deeper reconstruction of thick samples. Use of another clearing agent with distinct chemical properties may also help by providing better clearing. We have focused this study on ScaleA2 and SeeDB clearing agents, which provided enough clearing to reconstruct both myenteric and mucosal layers in murine midcolon but could not clear both layers sufficiently in distal colon, where the myenteric layer is thicker, hence motivating the manual removal of the myenteric layer in this protocol. We have successfully used the CUBIC reagents (37) to clear murine colorectal tissue (data not shown), but we do not have quantitative data comparing CUBIC with ScaleA2 or SeeDB in colon. Improvements in clearing will also help in the visualization of human colonic biopsies and tumor samples through their full depth.
Speed. Faster image acquisition through light-sheet illumination (20, 40, 43) , spinning-disk confocal imaging (8), or deconvolution microscopy (26) may aid in reconstruction of larger pieces of colon. Future parallel processing of images will likely accelerate image analysis.
Tips and Tricks
Several factors will need to be considered when deciding whether to use DMI and how best to apply it. DMI is well suited for addressing biological questions integrating over several length scales, for example, mechanisms of injury, inflammation, and tumorigenesis affecting multiple crypts that may be initiated by rare events or sparsely labeled cells such as stem cells. On a practical level we found that 3D reconstructions were easiest when imaging the native fluorescence of bright, genetically expressed fluorescent proteins, because the optical section thickness could be reduced while retaining signal and minimizing artifacts arising from inhomogeneous labeling by exogenous antibodies or dyes. Nonetheless it is very important to have a nucleus-labeling dye as a reference counterstain in DMI. All dyes and antibodies used must have high specificity for the target, otherwise they may be washed out during the clearing process or provide too much background. Because of lengthy and repeated illumination through the tissue volume, DMI demands that imaged proteins and dyes be photostable, which can be an issue for some nuclear labels and fluorescent proteins, although we have not encountered problems imaging EGFP or tdTomato. The selection of clearing agent is also important. When combining tissue clearing with other applications (e.g., immunohistochemistry), SeeDB provided more versatility and clearing speed; thus, SeeDB is a good "starter" reagent. However, in applications in which the expression of fluorescent proteins is weak, the tissue should be cleared with ScaleA2 to preserve the signals better. An alternative is to immunostain for the fluorescent protein and clear with SeeDB, but this requires additional optimization with antibodies. We prefer to test new experiments with SeeDB and only use ScaleA2 when the fluorescence preservation does not meet needs (Fig. 10) . For the use of DMI in other gastrointestinal organs, the removal of highly scattering tissue, optimization of penetration of clearing agent, and development of a mounting setup will have to be performed to obtain an in toto view of the sample of interest. We anticipate that the visualization of macroscopic biological processes at continuous microscopic detail in 3D will open new levels of understanding of the molecular, cellular, and tissue relationships in the digestive tract.
